The complexity of software architecture and diverse user interactions presents challenges to conventional testing approaches. Traditional test automation and quality assurance engineering represented ...
At the AMCP Annual Meeting, experts from Prime Therapeutics said education, policy alignment and collaboration can help ...
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat(R) KMT2A + MRD Assay and Software to its industry-leading ...
PlexusDx launches the first dedicated at-home genetic test for peptide biology, covering 14 pathways, 49 peptides, and ...
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...
Precision BioLogic originally developed CRYOcheck Chromogenic Factor VIII in response to a growing demand for chromogenic assays 1. Launched in 2020, it was the first commercially available, ...
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the validation study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results